Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RES | POET |
|---|---|---|
| Price | $6.10 | $7.81 |
| Change today | ▲ 4.10% | ▲ 0.26% |
| Market cap | $1.35B | $1.35B |
| Return, 3 months | +10.1% | -5.6% |
| Return, year to date | +14.4% | +23.4% |
| Return, 1 year | +30.8% | +22.4% |
| P/E (TTM) | 55.5 | -11.3 |
| P/B | 1.2 | 1.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.62% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 54 | 50 |
| 30-day volatility | 33.5% | 67.5% |
| Max drawdown, 1 year | -35.6% | -69.0% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
